75 related articles for article (PubMed ID: 20389159)
1. Sirolimus-based immunosuppression in kidney transplantation for type 2 diabetic nephropathy.
Veroux M; Corona D; Giuffrida G; Gagliano M; Vizcarra D; Tallarita T; Zerbo D; Giaquinta A; Sorbello M; Macarone M; Veroux P
Urol Int; 2010; 84(3):301-4. PubMed ID: 20389159
[TBL] [Abstract][Full Text] [Related]
2. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
Sundberg AK; Rohr MS; Hartmann EL; Adams PL; Stratta RJ
Clin Transplant; 2004; 18 Suppl 12():61-6. PubMed ID: 15217410
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus monotherapy as maintenance immunosuppression: single-center experience in 50 kidney transplant patients.
Arellano EM; Campistol JM; Oppenheimer F; Rovira J; Diekmann F
Transplant Proc; 2007 Sep; 39(7):2131-4. PubMed ID: 17889115
[TBL] [Abstract][Full Text] [Related]
5. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.
Steigerwalt SP; Brar N; Dhungel A; Butcher D; Steigerwalt S; El-Ghouroury M; Provenzano R
Transplant Proc; 2009 Dec; 41(10):4184-7. PubMed ID: 20005365
[TBL] [Abstract][Full Text] [Related]
6. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
7. Renal transplantation in diabetic patients.
Bittar J; Cepeda P; de la Fuente J; Douthat W; de Arteaga J; Massari PU
Transplant Proc; 2006 Apr; 38(3):895-8. PubMed ID: 16647502
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
9. Rejection after simultaneous pancreas-kidney transplantation.
Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
[TBL] [Abstract][Full Text] [Related]
11. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation.
Freise CE; Kang SM; Feng S; Posselt A; Hirose K; Hirose R; Stock P
Transplant Proc; 2004 May; 36(4):1067-8. PubMed ID: 15194370
[TBL] [Abstract][Full Text] [Related]
12. Sirolimus in kidney transplantation from marginal donors.
Pisani F; Buonomo O; Iaria G; Iorio B; Rizzello A; Pollicita S; De Luca L; Valeri M; Boffo V; Famulari A; Casciani CU
Transplant Proc; 2004 Apr; 36(3):495-6. PubMed ID: 15110569
[TBL] [Abstract][Full Text] [Related]
13. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
14. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.
Benavides CA; Pollard VB; Mauiyyedi S; Podder H; Knight R; Kahan BD
Transplantation; 2007 Jul; 84(1):83-8. PubMed ID: 17627242
[TBL] [Abstract][Full Text] [Related]
15. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols.
Steurer W; Malaise J; Mark W; Koenigsrainer A; Margreiter R;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii54-62. PubMed ID: 15814551
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of tacrolimus therapy for renal transplantation in patients with diabetic nephropathy in Japan.
Sugitani A; Tanaka M; Takahara S; Uchida K; Yoshimura N; Takahashi K; Toma H; Oshima S; Sonoda T;
Transplant Proc; 2005 May; 37(4):1767-8. PubMed ID: 15919459
[TBL] [Abstract][Full Text] [Related]
18. Kidney-pancreas transplants: is it so difficult to start a program?
Alonso A; Fernández C; Villaverde P; García R; Aguirrezabalaga J; Gómez M; Oliver J; Valdés F
Transplant Proc; 2005 Apr; 37(3):1455-6. PubMed ID: 15866636
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous pancreas-kidney transplant from living related donor: a single-center experience.
Zieliński A; Nazarewski S; Bogetti D; Sileri P; Testa G; Sankary H; Benedetti E
Transplantation; 2003 Aug; 76(3):547-52. PubMed ID: 12923442
[TBL] [Abstract][Full Text] [Related]
20. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
Schulz T; Papapostolou G; Schenker P; Kapischke M
Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
